Stockscreener 앱 받기
9.2843
0.56%
0.0543
전일 마감가:
$9.23
열려 있는:
$9.32
하루 거래량:
228.19K
Relative Volume:
0.27
시가총액:
$327.71M
수익:
$2.07M
순이익/손실:
$-47.68M
주가수익비율:
-3.2923
EPS:
-2.82
순현금흐름:
$-31.31M
1주 성능:
+9.07%
1개월 성능:
-9.27%
6개월 성능:
-42.39%
1년 성능:
-12.85%
1일 변동 폭
$9.15
$9.388
1주일 범위
$8.12
$9.39
52주 변동 폭
$8.12
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
명칭
Delcath Systems Inc
전화
(518) 743-8892
주소
566 QUEENSBURY AVENUE, QUEENSBURY, NY
DCTH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
9.28 | 325.95M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
128.88 | 222.66B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
101.29 | 150.26B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
371.66 | 143.44B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
105.95 | 135.12B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
86.84 | 50.38B | 5.88B | 1.34B | 799.60M | 2.3489 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 개시 | Craig Hallum | Buy |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2022-07-26 | 재개 | Canaccord Genuity | Buy |
| 2021-12-10 | 개시 | H.C. Wainwright | Buy |
| 2021-03-09 | 개시 | Canaccord Genuity | Buy |
| 2021-01-05 | 개시 | BTIG Research | Buy |
| 2020-06-01 | 개시 | Laidlaw | Buy |
모두보기
Delcath Systems Inc 주식(DCTH)의 최신 뉴스
Do Options Traders Know Something About Delcath Systems Stock We Don't? - Yahoo Finance
Delcath Systems, Inc. (NASDAQ:DCTH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH) and ClearPoint Neuro (CLPT) - The Globe and Mail
Delcath Systems (NASDAQ:DCTH) Board Authorizes Stock Repurchase Plan - MarketBeat
Responsive Playbooks and the DCTH Inflection - news.stocktradersdaily.com
Delcath Systems authorizes $25 million share repurchase program - MSN
Why We're Not Concerned Yet About Delcath Systems, Inc.'s (NASDAQ:DCTH) 28% Share Price Plunge - simplywall.st
Delcath Systems authorizes $25 million share repurchase program By Investing.com - Investing.com Canada
Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program - BioSpace
How supply shortages influence Delcath Systems Inc. (DV3R) stockEarnings Growth Summary & Entry and Exit Point Strategies - newser.com
Biotech Stocks Swing After Hours: Delcath Rises On Buyback, BioVie And Cassava Rebound - Nasdaq
Delcath Systems board authorizes $25 million share repurchase program By Investing.com - Investing.com Australia
Delcath Systems board authorizes $25 million share repurchase program - Investing.com India
Delcath Systems (DCTH) Initiates $25 Million Share Buyback Progr - GuruFocus
Delcath Systems Announces $25M Share Buyback Plan - TipRanks
[8-K] DELCATH SYSTEMS, INC. Reports Material Event | DCTH SEC FilingForm 8-K - Stock Titan
Delcath Systems, Inc. announces an Equity Buyback for $25 million worth of its shares. - MarketScreener
Delcath Systems board of directors authorizes $25 million share repurchase program - MarketScreener
Domino's Pizza (Nasdaq: DPZ) brings back $9.99 any-topping pizzas promotion - Stock Titan
Can Delcath Systems Inc. (DV3R) stock beat analyst consensusWeekly Trade Analysis & Consistent Profit Trade Alerts - newser.com
Can Delcath Systems Inc. (DV3R) stock attract ESG investmentsWeekly Loss Report & Technical Analysis for Trade Confirmation - newser.com
What analyst consensus says on Delcath Systems Inc. stockBear Alert & Verified Trade Idea Suggestions - newser.com
Forecasting Delcath Systems Inc. price range with options dataJuly 2025 Momentum & Risk Managed Investment Entry Signals - newser.com
How Delcath Systems Inc. (DV3R) stock reacts to Fed tighteningDollar Strength & Free Reliable Trade Execution Plans - newser.com
Delcath Systems Shares Tick Higher After Study Highlights Strong Outcomes for Liver Cancer Treatment - MSN
Will Delcath Systems Inc. stock reach all time highs in 2025Market Performance Recap & AI Driven Stock Price Forecasts - newser.com
Real time breakdown of Delcath Systems Inc. stock performanceJuly 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com
Why Delcath Systems Inc. (DV3R) stock trades below fair value2025 Valuation Update & Weekly High Return Opportunities - newser.com
Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma - BioSpace
Is Delcath Systems Inc. showing signs of accumulation - newser.com
Will Delcath Systems Inc. benefit from macro trends2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com
Will Delcath Systems Inc. (DV3R) stock issue positive guidanceMarket Sentiment Review & Risk Adjusted Buy/Sell Alerts - newser.com
Volatility clustering patterns for Delcath Systems Inc.Breakout Watch & Free Growth Oriented Trading Recommendations - newser.com
Delcath Systems, Inc. authorizes a Buyback Plan. - MarketScreener
Delcath Systems (DCTH) Highlights Promising Results for Liver Me - GuruFocus
H.C. Wainwright Reiterates a Buy on Delcath Systems (DCTH), Lowers the PT - Insider Monkey
Delcath Systems Inc (DCTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Delcath Systems Inc 주식 (DCTH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| MICHEL GERARD J | CHIEF EXECUTIVE OFFICER |
Nov 11 '25 |
Buy |
8.53 |
11,500 |
98,049 |
330,834 |
| Vukovic Vojo | CHIEF MEDICAL OFFICER |
Jun 12 '25 |
Option Exercise |
4.78 |
42,000 |
200,760 |
168,882 |
0.21%
1.32%
자본화:
|
볼륨(24시간):